Renova Therapeutics Overview
- Year Founded
-
2009
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Investors
-
4
Renova Therapeutics General Information
Description
Operator of a biotechnology research company intended to advance gene therapies for chronic conditions involving cardiovascular and metabolic disease. The company offers targeted gene therapy modalities and proprietary delivery approaches, enabling healthcare providers, researchers, and patients access to treatments that address the underlying drivers of long-term disease progression.
Contact Information
Website
www.renovatherapeutics.comCorporate Office
- 701 Palomar Airport Road
- Suite 300
- Carlsbad, CA 92011
- United States
Corporate Office
- 701 Palomar Airport Road
- Suite 300
- Carlsbad, CA 92011
- United States
Renova Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | In Progress | Clinical Trials - Phase 2 | ||||
| 10. Later Stage VC | 02-Feb-2024 | Completed | Product Development | |||
| 9. Grant | 20-Sep-2019 | Completed | Product Development | |||
| 8. Later Stage VC (Series D1) | 31-Jan-2017 | Completed | Product Development | |||
| 7. Later Stage VC (Series D) | 23-Feb-2016 | Completed | Product Development | |||
| 6. Grant | 01-Jan-2016 | Completed | Product Development | |||
| 5. Later Stage VC (Series C) | 30-Sep-2014 | Completed | Product Development | |||
| 4. Early Stage VC (Series B) | 25-Feb-2012 | Completed | Product Development | |||
| 3. Grant | 02-Sep-2011 | $250K | $3.05M | Completed | Startup | |
| 2. Early Stage VC (Series A) | 10-Aug-2009 | $3.05M | $3.05M | Completed | Startup |
Renova Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 320,292 | $0.001000 | $1.23 | $24.6 | $24.6 | 1x | $24.6 | 10.46% |
| Series A | 305,000 | $0.001000 | $0.5 | $10 | $10 | 1x | $10 | 9.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Renova Therapeutics Comparisons
Industry
Financing
Details
Renova Therapeutics Competitors (85)
One of Renova Therapeutics’s 85 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Emmaus Life Sciences | Formerly VC-backed | Torrance, CA | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Jaguar Gene Therapy | Venture Capital-Backed | Lake Forest, IL |
Renova Therapeutics Patents
Renova Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018090036-A1 | Method of protection for cardiac tissue | Inactive | 14-Nov-2016 | ||
| WO-2018090042-A1 | Methods of treating heart failure | Inactive | 14-Nov-2016 |
Renova Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Heart, Lung, and Blood Institute | Government | |||
| Biobrit | Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| University of California, San Diego | University |
Renova Therapeutics FAQs
-
When was Renova Therapeutics founded?
Renova Therapeutics was founded in 2009.
-
Where is Renova Therapeutics headquartered?
Renova Therapeutics is headquartered in Carlsbad, CA.
-
What industry is Renova Therapeutics in?
Renova Therapeutics’s primary industry is Pharmaceuticals.
-
Is Renova Therapeutics a private or public company?
Renova Therapeutics is a Private company.
-
What is Renova Therapeutics’s current revenue?
The current revenue for Renova Therapeutics is .
-
How much funding has Renova Therapeutics raised over time?
Renova Therapeutics has raised $78.1M.
-
Who are Renova Therapeutics’s investors?
National Heart, Lung, and Blood Institute, Biobrit, National Institutes of Health, and University of California, San Diego have invested in Renova Therapeutics.
-
Who are Renova Therapeutics’s competitors?
BioMarin Pharmaceutical, Emmaus Life Sciences, Dicerna Pharmaceuticals, Pfizer (Vienna), and Jaguar Gene Therapy are some of the 85 competitors of Renova Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process